| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.11. | Acarix AB: Acarix Publishes Third Quarter 2026 Results | 126 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the third quarter of 2026. The quarter delivered the highest revenue... ► Artikel lesen | |
| 08.10. | Acarix AB: Acarix Provides Update on RHTP and Saudi Arabia Regulatory Process | 285 | GlobeNewswire (Europe) | Acarix has received several inquiries from shareholders regarding the status of the U.S. Rural Health Transformation Program (RHTP) and regulatory approval in the Kingdom of Saudi Arabia (KSA) and would... ► Artikel lesen | |
| 11.09. | Acarix AB: Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test | 486 | GlobeNewswire (Europe) | Aalborg University-led research, published in PLOS Digital Health, found the CADScor System's acoustic sensing platform identified heart failure with diagnostic accuracy comparable to a leading blood... ► Artikel lesen | |
| 13.08. | Acarix AB Q2 Sales Increase | 10 | RTTNews | ||
| 13.08. | Earnings Call: Acarix meldet starkes Wachstum für Q2 2026, doch die Aktie gibt nach | 10 | Investing.com Deutsch | ||
| 13.08. | Acarix Q2 2026 slides: revenue doubles as US growth accelerates | 1 | Investing.com | ||
| 13.08. | Acarix Q2 2026 slides: US revenue surges 212%, losses narrow | 5 | Investing.com | ||
| ACARIX Aktie jetzt für 0€ handeln | |||||
| 13.08. | Acarix AB: Acarix Publishes Second Quarter and First Half 2026 Results | 286 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the second quarter and first half 2026. The report highlights continued commercial... ► Artikel lesen | |
| 17.06. | Acarix AB: Announcement from the annual general meeting in Acarix AB | 331 | GlobeNewswire (Europe) | The annual general meeting 2026 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 17 June 2026 and the following resolutions were passed by the meeting.
Adoption of the income statement... ► Artikel lesen | |
| 18.05. | Acarix AB: Acarix Publishes Interim Report, January - March 2026 | 369 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarter of 2026. The report highlights meaningful progress across the... ► Artikel lesen | |
| 12.02. | Acarix AB: Acarix Publishes Year-End Report 2025 | 365 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end financial results. "Last year was a year of meaningful commercial and operational... ► Artikel lesen | |
| 11.02. | Acarix AB: Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System | 594 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics for coronary artery disease, today announced that it has entered into a strategic... ► Artikel lesen | |
| 04.02. | Acarix AB: Acarix Receives EU MDR Certification for the CADScorSystem | 467 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor System has successfully achieved certification under the European Union Medical... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,760 | +2,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,060 | -0,62 % | Carl Zeiss Meditec-Aktie -3%: Jetzt die Reißleine ziehen? | Die Aktie von Carl Zeiss Meditec gab am Mittwoch zeitweise mehr als 3% nach, FMC verlor im Dax bis zu 2%. Beide Titel konnten sich damit der Stabilisierung am Gesamtmarkt nicht anschließen, Auslöser... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,560 | -1,29 % | Eckert & Ziegler Aktie: Isotopen-Boom lässt Analysten aufhorchen | Die starke Nachfrage nach radioaktiven Isotopen für die Krebstherapie sorgt bei Eckert & Ziegler für steigende Gewinne und positive Analystenstimmen. Berenberg erhöht nach den Quartalszahlen das Kursziel... ► Artikel lesen | |
| UNITEDHEALTH | 313,00 | +3,99 % | UnitedHealth-Aktie -15%: Washington zieht die Daumenschrauben an - trotzdem kaufen? | Es ist bislang eine rabenschwarze Woche für die UnitedHealth-Aktie. Am Dienstag und am Mittwoch brach der Kurs der größten privaten US-Krankenversicherung in Summe um -15% ein. Was steckt hinter dem... ► Artikel lesen | |
| HIMS & HERS HEALTH | 13,930 | -4,59 % | Hims & Hers Health, Inc: Hers launches free Metabolic Deep Dive to help show UK women what's really holding back their weight loss | Hers launches free Metabolic Deep Dive to help show UK women what's really holding back their weight loss
New YouGov research finds 61% of UK women are trying to lose weight, yet many are working... ► Artikel lesen | |
| BICO GROUP | 1,376 | -2,41 % | BICO Group AB reports Q3 results | ||
| NUGEN MEDICAL DEVICES | 0,011 | -100,00 % | NuGen Medical Devices Inc.: NuGen Medical Devices Provides Update on Health Canada Licence Application | Toronto, Ontario--(Newsfile Corp. - November 13, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a developer of needle-free drug delivery technology, provides an update regarding... ► Artikel lesen | |
| SPINEWAY | 0,093 | +8,63 % | Spineway: H1 2026 results | H1 2026 results Continued growth Stable resultsStrong embedded growth driversIssuance of straight bonds to finance future growth In thousands of eurosConsolidated financial statements - UnauditedH1... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences GAAP EPS of $0.00, revenue of $4.63M | ||
| UNIDOC HEALTH | 0,028 | -5,96 % | CSE Bulletin: Reinstatement - UniDoc Health Corp. (UDOC) | Le 7 octobre/October 2026
Effective immediately, UniDoc Health Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
__________________________
En... ► Artikel lesen | |
| VERU | 2,145 | +1,66 % | Veru presents data on enobosarm for obesity treatment | ||
| VIROMED MEDICAL | 3,480 | -6,45 % | EQS-Adhoc: Viromed Medical AG: Veränderungen im Vorstand | EQS-Ad-hoc: Viromed Medical AG / Schlagwort(e): Personalentscheidungen / Vorstand
Viromed Medical AG: Veränderungen im Vorstand
16.11.2026 / 17:57 CET/CEST
Veröffentlichung einer... ► Artikel lesen | |
| BONESUPPORT | 28,740 | +0,21 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q3 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2026.
"Strong growth and important progress... ► Artikel lesen | |
| CLARIANE | 3,324 | +0,42 % | Clariane: Signing of a new €700 million syndicated revolving credit facility maturing 2031 | 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026: following the success of its €500 million senior bonds offering completed on 8 September... ► Artikel lesen | |
| SENSEONICS | 8,800 | +8,64 % | Beta Bionics, Inc.: Senseonics and Beta Bionics Launch Eversense 365 and iLet Bionic Pancreas Integration |